| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO
1 company
Przybyl Arthur is a President And CEO at ANI PHARMACEUTICALS INC. Recent SEC Form 4 filings include 1 buy and 13 sells.
Estimated insider holdings value: $15.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 15, 2019 | ANIP Ani Pharmaceuticals Inc | President And CEO | Sell | 30,000 | $70.07 | $2,102,177.15 | -4.5% | |
| Mar 19, 2019 | ANIP Ani Pharmaceuticals Inc | President And CEO | Sale+OE | 27,625 | $63.53 | $1,754,959.79 | -6.3% | |
| Mar 14, 2018 | ANIP Ani Pharmaceuticals Inc | President And CEO | Sale+OE | 40,000 | $61.83 | $2,473,142.75 | -6.4% | |
| Mar 1, 2018 | ANIP Ani Pharmaceuticals Inc | President And CEO | Sale+OE | 23,986 | $61.23 | $1,468,694.54 | -3.6% | |
| Aug 22, 2016 | ANIP Ani Pharmaceuticals Inc | President And CEO | Sale+OE | 37,455 | $66.97 | $2,508,361.35 | -16.3% | |
| Nov 12, 2015 | ANIP Ani Pharmaceuticals Inc | President And CEO | Buy | 2,500 | $40.95 | $102,375.00 | +1.8% | |
| Mar 12, 2015 | ANIP Ani Pharmaceuticals Inc | President And CEO | Sell | 75,000 | $63.00 | $4,725,000.00 | -39.6% |